2Thiele H, Lauer B, Hambreeht R, et al. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral atrial bypass assistance[J].Circulation,2001,104 : 2917-2922.
3Black A, Cortina R, Bossi I, et al. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection[J]. J Am Coll Cardiol,2001,37: 832-838.
4Lee MS, Makkar RR. Percutaneous left ventricular support devices[J]. Cardiol Clin, 2006,24:265-275.
5Kar B, Butkevich A, Civitello AB, et al. Hemodynamic support with a pereutaneous left ventrieular assist device [J].Tex Heart Inst J,2004,31:84-86.
6Vranckx P, Foley DP, de Feijter PJ, et al. Effective use of the TandemHeart during high-risk percutaneous coronary intervention[J].Int J Cardiovasc Intervent, 2003,5 :35-39.
7Becker RC, Gore JM, Lambrew C, et al. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction[J]. J Am Coil Cardiol, 1996, 27:1321-1326.
8Domanski MJ, Topoi EJ. Cardiogenic shock., current understandings and future research direction[J]. Am J Cardiol, 1994,74:724.
9DeWood MA, Notske RN, Hensley GR, et al. Intraaortic balloon eounterpulsation with and without reperfusion for myocardial infarction shock[J]. Circulation, 1980, 61:1105-1112.
10Chen JM, DeRose JJ, Slater JP. Improved survival rates support LVAD implantation early after myocardial infarction [J].J Am Coll Cardiol,1999,33:1903-1908.
